Skip to main content
Unknown status

Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 72

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 22k/06/08

Study First Received: January 17, 2011

Last Updated: January 21, 2011

Estimated Primary Completion Date: August 2014

 

Primary Outcome Measures:

Progression free survival|Overall survival

Sponsors and Collaborators:

Institute of Oncology Ljubljana|Slovenian Research Agency

Website Link: https://ClinicalTrials.gov/show/NCT01281800

Leave a Reply